BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25265427)

  • 1. Expression of Proteinase-activated Receptor-2 in the Esophageal Mucosa of Gastroesophageal Reflux Disease Patients: A Histomorphologic and Immunohistochemical Study.
    Abd El-Rehim DM; Fath El-Bab HK; Kamal EM
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):646-52. PubMed ID: 25265427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease.
    Kandulski A; Wex T; Mönkemüller K; Kuester D; Fry LC; Roessner A; Malfertheiner P
    Am J Gastroenterol; 2010 Sep; 105(9):1934-43. PubMed ID: 20588261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis.
    Weijenborg PW; Smout AJ; Verseijden C; van Veen HA; Verheij J; de Jonge WJ; Bredenoord AJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G323-9. PubMed ID: 24924748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease.
    Woodland P; Shen Ooi JL; Grassi F; Nikaki K; Lee C; Evans JA; Koukias N; Triantos C; McDonald SA; Peiris M; Aktar R; Blackshaw LA; Sifrim D
    Gastroenterology; 2017 Nov; 153(5):1230-1239. PubMed ID: 28734832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease.
    Mönkemüller K; Wex T; Kuester D; Fry LC; Peitz U; Beyer M; Roessner A; Malfertheiner P
    Digestion; 2009; 79(3):186-95. PubMed ID: 19342859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heartburn sensation in nonerosive reflux disease: pattern of superficial sensory nerves expressing TRPV1 and epithelial cells expressing ASIC3 receptors.
    Ustaoglu A; Sawada A; Lee C; Lei WY; Chen CL; Hackett R; Sifrim D; Peiris M; Woodland P
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G804-G815. PubMed ID: 33655767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of protease-activated-receptor 2 (PAR-2) in human esophageal mucosa.
    Inci K; Edebo A; Olbe L; Casselbrant A
    Scand J Gastroenterol; 2009; 44(6):664-71. PubMed ID: 19263271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
    Wex T; Mönkemüller K; Kuester D; Weise S; Kropf S; Fry LC; Stahr A; Völkel S; Roessner A; Malfertheiner P
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel immune cell signature in gastroesophageal reflux disease: altered mucosal mast cells and dendritic cell profile.
    Ustaoglu A; Daudali FA; D'afflitto M; Murtough S; Lee C; Moreno E; Blaydon DC; Kelsell DP; Sifrim D; Woodland P; Peiris M
    Front Immunol; 2023; 14():1282577. PubMed ID: 38098488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of dilated intercellular space and histopathologic scores in gastroesophageal reflux disease.
    Cui R; Zhang H; Zhou L; Lu J; Xue Y; Wang Y; Yan X; Lin L; Lin S
    Dis Esophagus; 2015; 28(6):530-7. PubMed ID: 25130660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
    Winter JW; Heading RC
    Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms.
    Kim JJ; Kim N; Choi YJ; Kim JS; Jung HC
    Medicine (Baltimore); 2016 Aug; 95(32):e4387. PubMed ID: 27512850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease.
    Yoshida N; Uchiyama K; Kuroda M; Sakuma K; Kokura S; Ichikawa H; Naito Y; Takemura T; Yoshikawa T; Okanoue T
    Scand J Gastroenterol; 2004 Sep; 39(9):816-22. PubMed ID: 15513378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bringing GERD Management up to PAR-2.
    Souza RF
    Am J Gastroenterol; 2010 Sep; 105(9):1944-6. PubMed ID: 20818348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of acid sensing ion channels is associated with esophageal hypersensitivity in GERD.
    Han X; Zhang Y; Lee A; Li Z; Gao J; Wu X; Zhao J; Wang H; Chen D; Zou D; Owyang C
    FASEB J; 2022 Jan; 36(1):e22083. PubMed ID: 34918385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
    Hershcovici T; Jha LK; Fass R
    J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
    Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
    Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.